nodes	percent_of_prediction	percent_of_DWPC	metapath
Piroxicam—osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.48	1	CpDpCtD
Piroxicam—ALB—chronic obstructive pulmonary disease	0.245	1	CbGaD
Piroxicam—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0719	0.289	CbGbCtD
Piroxicam—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0415	0.167	CbGbCtD
Piroxicam—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0382	0.154	CbGbCtD
Piroxicam—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0382	0.154	CbGbCtD
Piroxicam—ALB—Prednisone—chronic obstructive pulmonary disease	0.0298	0.12	CbGbCtD
Piroxicam—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.029	0.116	CbGbCtD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000143	0.00536	CbGpPWpGaD
Piroxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000141	0.0053	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000141	0.00529	CbGpPWpGaD
Piroxicam—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.00014	0.00527	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00014	0.00526	CbGpPWpGaD
Piroxicam—PTGS2—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000134	0.00501	CbGpPWpGaD
Piroxicam—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000131	0.00493	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.000131	0.0049	CbGpPWpGaD
Piroxicam—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00013	0.00488	CbGpPWpGaD
Piroxicam—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.00477	CbGpPWpGaD
Piroxicam—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.00471	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000124	0.00467	CbGpPWpGaD
Piroxicam—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00012	0.00449	CbGpPWpGaD
Piroxicam—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000116	0.00436	CbGpPWpGaD
Piroxicam—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.00435	CbGpPWpGaD
Piroxicam—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000114	0.00429	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000114	0.00428	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000113	0.00425	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000108	0.00405	CbGpPWpGaD
Piroxicam—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.00401	CbGpPWpGaD
Piroxicam—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000106	0.00397	CbGpPWpGaD
Piroxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000104	0.00388	CbGpPWpGaD
Piroxicam—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000103	0.00387	CbGpPWpGaD
Piroxicam—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000102	0.00383	CbGpPWpGaD
Piroxicam—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000102	0.00383	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000101	0.00378	CbGpPWpGaD
Piroxicam—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000101	0.00378	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	9.34e-05	0.0035	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	9.28e-05	0.00348	CbGpPWpGaD
Piroxicam—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.24e-05	0.00346	CbGpPWpGaD
Piroxicam—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	9.23e-05	0.00346	CbGpPWpGaD
Piroxicam—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	9.15e-05	0.00343	CbGpPWpGaD
Piroxicam—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.12e-05	0.00342	CbGpPWpGaD
Piroxicam—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.7e-05	0.00326	CbGpPWpGaD
Piroxicam—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.48e-05	0.00318	CbGpPWpGaD
Piroxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.39e-05	0.00315	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	8.34e-05	0.00313	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	7.58e-05	0.00284	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	7.55e-05	0.00283	CbGpPWpGaD
Piroxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.52e-05	0.00282	CbGpPWpGaD
Piroxicam—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.49e-05	0.00281	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	7.43e-05	0.00279	CbGpPWpGaD
Piroxicam—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.42e-05	0.00278	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	7.42e-05	0.00278	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	7.17e-05	0.00269	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.17e-05	0.00269	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	7.16e-05	0.00268	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	7.13e-05	0.00267	CbGpPWpGaD
Piroxicam—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.07e-05	0.00265	CbGpPWpGaD
Piroxicam—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.59e-05	0.00247	CbGpPWpGaD
Piroxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	6.58e-05	0.00247	CbGpPWpGaD
Piroxicam—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.52e-05	0.00244	CbGpPWpGaD
Piroxicam—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.5e-05	0.00244	CbGpPWpGaD
Piroxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	6.19e-05	0.00232	CbGpPWpGaD
Piroxicam—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.16e-05	0.00231	CbGpPWpGaD
Piroxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.1e-05	0.00229	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	6e-05	0.00225	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	5.95e-05	0.00223	CbGpPWpGaD
Piroxicam—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	5.92e-05	0.00222	CbGpPWpGaD
Piroxicam—SLC22A11—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.84e-05	0.00219	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	5.83e-05	0.00218	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	5.8e-05	0.00217	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	5.8e-05	0.00217	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	5.79e-05	0.00217	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	5.74e-05	0.00215	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	5.69e-05	0.00213	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.69e-05	0.00213	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	5.68e-05	0.00213	CbGpPWpGaD
Piroxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	5.64e-05	0.00211	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	5.62e-05	0.00211	CbGpPWpGaD
Piroxicam—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.48e-05	0.00205	CbGpPWpGaD
Piroxicam—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.4e-05	0.00203	CbGpPWpGaD
Piroxicam—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.36e-05	0.00201	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	5.35e-05	0.002	CbGpPWpGaD
Piroxicam—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.3e-05	0.00199	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	5.28e-05	0.00198	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	5.2e-05	0.00195	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	5.03e-05	0.00188	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	4.97e-05	0.00186	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	4.96e-05	0.00186	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.94e-05	0.00185	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	4.74e-05	0.00178	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	4.71e-05	0.00177	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.63e-05	0.00174	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	4.63e-05	0.00173	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	4.61e-05	0.00173	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.61e-05	0.00173	CbGpPWpGaD
Piroxicam—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.57e-05	0.00171	CbGpPWpGaD
Piroxicam—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.51e-05	0.00169	CbGpPWpGaD
Piroxicam—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.46e-05	0.00167	CbGpPWpGaD
Piroxicam—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.46e-05	0.00167	CbGpPWpGaD
Piroxicam—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.4e-05	0.00165	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.23e-05	0.00159	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	4.2e-05	0.00158	CbGpPWpGaD
Piroxicam—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.2e-05	0.00157	CbGpPWpGaD
Piroxicam—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.14e-05	0.00155	CbGpPWpGaD
Piroxicam—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.98e-05	0.00149	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	3.94e-05	0.00148	CbGpPWpGaD
Piroxicam—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.93e-05	0.00147	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	3.81e-05	0.00143	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.77e-05	0.00141	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.77e-05	0.00141	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	3.74e-05	0.0014	CbGpPWpGaD
Piroxicam—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.72e-05	0.00139	CbGpPWpGaD
Piroxicam—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.72e-05	0.00139	CbGpPWpGaD
Piroxicam—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.67e-05	0.00137	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	3.66e-05	0.00137	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.53e-05	0.00133	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	3.45e-05	0.00129	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	3.42e-05	0.00128	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	3.42e-05	0.00128	CbGpPWpGaD
Piroxicam—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.42e-05	0.00128	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.41e-05	0.00128	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	3.39e-05	0.00127	CbGpPWpGaD
Piroxicam—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.37e-05	0.00126	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.36e-05	0.00126	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.28e-05	0.00123	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	3.26e-05	0.00122	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.26e-05	0.00122	CbGpPWpGaD
Piroxicam—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.24e-05	0.00121	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	3.2e-05	0.0012	CbGpPWpGaD
Piroxicam—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.19e-05	0.0012	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	3.19e-05	0.0012	CbGpPWpGaD
Piroxicam—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	3.18e-05	0.00119	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.15e-05	0.00118	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	3.14e-05	0.00118	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	3.01e-05	0.00113	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	2.99e-05	0.00112	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	2.99e-05	0.00112	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.97e-05	0.00111	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.97e-05	0.00111	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	2.84e-05	0.00107	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.81e-05	0.00105	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	2.79e-05	0.00105	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	2.76e-05	0.00103	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	2.72e-05	0.00102	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.71e-05	0.00102	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	2.65e-05	0.000995	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.61e-05	0.000977	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.61e-05	0.000977	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.59e-05	0.000971	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.59e-05	0.000969	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	2.54e-05	0.000951	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.37e-05	0.000887	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.36e-05	0.000884	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	2.34e-05	0.000877	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.32e-05	0.000871	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.28e-05	0.000856	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.27e-05	0.000851	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.26e-05	0.000849	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.21e-05	0.000827	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.19e-05	0.000822	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	2.14e-05	0.000803	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.12e-05	0.000795	CbGpPWpGaD
Piroxicam—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.11e-05	0.000791	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.11e-05	0.00079	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.1e-05	0.000789	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.1e-05	0.000785	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.09e-05	0.000784	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.06e-05	0.000774	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.05e-05	0.000769	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.93e-05	0.000725	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.92e-05	0.000719	CbGpPWpGaD
Piroxicam—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.91e-05	0.000715	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.9e-05	0.000711	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.89e-05	0.000708	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.88e-05	0.000704	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.86e-05	0.000697	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.81e-05	0.000677	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.75e-05	0.000654	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.73e-05	0.000647	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.72e-05	0.000647	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.71e-05	0.000642	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.68e-05	0.00063	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.64e-05	0.000613	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.61e-05	0.000603	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.59e-05	0.000597	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.57e-05	0.00059	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.56e-05	0.000585	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.53e-05	0.000573	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.52e-05	0.00057	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.52e-05	0.000569	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.5e-05	0.000561	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.47e-05	0.000551	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.45e-05	0.000544	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.39e-05	0.000522	CbGpPWpGaD
Piroxicam—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	1.39e-05	0.000521	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.39e-05	0.000519	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.37e-05	0.000513	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.35e-05	0.000506	CbGpPWpGaD
Piroxicam—PTGS2—Disease—KL—chronic obstructive pulmonary disease	1.29e-05	0.000485	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.28e-05	0.000479	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.25e-05	0.000468	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.000466	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.21e-05	0.000453	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.19e-05	0.000447	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.15e-05	0.000432	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.14e-05	0.000426	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.13e-05	0.000423	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.12e-05	0.00042	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.11e-05	0.000418	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.11e-05	0.000417	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.11e-05	0.000415	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.09e-05	0.000407	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.05e-05	0.000395	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.04e-05	0.000389	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.02e-05	0.000381	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.01e-05	0.000379	CbGpPWpGaD
Piroxicam—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	9.69e-06	0.000363	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.6e-06	0.00036	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.47e-06	0.000355	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.37e-06	0.000351	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.31e-06	0.000349	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.17e-06	0.000344	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	9.07e-06	0.00034	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.82e-06	0.000331	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.46e-06	0.000317	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.37e-06	0.000314	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	8.28e-06	0.00031	CbGpPWpGaD
Piroxicam—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	8.08e-06	0.000303	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	7.82e-06	0.000293	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.81e-06	0.000293	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.77e-06	0.000291	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.71e-06	0.000289	CbGpPWpGaD
Piroxicam—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.66e-06	0.000287	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.62e-06	0.000286	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.18e-06	0.000269	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.18e-06	0.000269	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	7.16e-06	0.000269	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.14e-06	0.000268	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.85e-06	0.000257	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.81e-06	0.000255	CbGpPWpGaD
Piroxicam—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	6.8e-06	0.000255	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.77e-06	0.000254	CbGpPWpGaD
Piroxicam—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	6.49e-06	0.000243	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.36e-06	0.000238	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.27e-06	0.000235	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	5.91e-06	0.000221	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.84e-06	0.000219	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	5.69e-06	0.000213	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.54e-06	0.000208	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.44e-06	0.000204	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	4.63e-06	0.000173	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.43e-06	0.000166	CbGpPWpGaD
Piroxicam—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	4.4e-06	0.000165	CbGpPWpGaD
Piroxicam—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	4.29e-06	0.000161	CbGpPWpGaD
Piroxicam—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	4.21e-06	0.000158	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.77e-06	0.000141	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.6e-06	0.000135	CbGpPWpGaD
Piroxicam—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	3.24e-06	0.000121	CbGpPWpGaD
